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Aim:  This  study  investigated  the value  of regional  cerebral  oxygen  saturation  (rSO2)  monitoring  uponeceived in revised form 8 July 2015




arrival  at  the  hospital  for predicting  post-cardiac  arrest  intervention  outcomes.
Methods: We  enrolled  1195 patients  with  out-of-hospital  cardiac  arrest  of presumed  cardiac  cause  from
the Japan-Prediction  of Neurological  Outcomes  in Patients  Post-cardiac  Arrest  Registry.  The primary
endpoint  was  a good  neurologic  outcome  (cerebral  performance  categories  1  or  2  [CPC1/2])  90  days
post-event.
Results:  A  total  of 68  patients  (6%)  had  good  neurologic  outcomes.  We  found  a  mean  rSO2 of 21% ±  13%.
A  receiver  operating  characteristic  curve  analysis  indicated  an  optimal  rSO2 cut-off  of ≥40%  for  good
Abbreviations: AUC, area under the curve; CAG, coronary angiography; CI, conﬁdence interval; CPC, Glasgow–Pittsburgh cerebral performance category; CPR, cardiopul-
onary  resuscitation; GCS, Glasgow Coma Scale; J-POP, Japan-Prediction of Neurological Outcomes in Patients Post-Cardiac Arrest; OHCA, out-of-hospital cardiac arrest; PCAI,
ost-cardiac arrest intervention; PCI, percutaneous coronary intervention; ROC, receiver operating characteristic; ROSC, return of spontaneous circulation; rSO2, regional
erebral oxygen saturation; TH, therapeutic hypothermia.
 A Spanish translated version of the abstract of this article appears as Appendix in the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2015.07.049.
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ttp://dx.doi.org/10.1016/j.resuscitation.2015.07.049
300-9572/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
c-nd/4.0/).




neurologic  outcomes  (area  under  the  curve  0.92,  sensitivity  0.81,  speciﬁcity  0.96).  Good  neurologic  out-
comes  were  observed  in  53%  (55/103)  and  1%  (13/1092)  of  patients  with  high  (≥40%)  and  low  (<40%)
rSO2,  respectively.  Even  without  return of  spontaneous  circulation  (ROSC)  upon  arrival  at the hospital,  30%
(9/30)  of  patients  with  high  rSO2 had  good  neurologic  outcomes.  Furthermore,  16 patients  demonstrating
ROSC  upon  arrival  at  the hospital  and  low  rSO2 had  poor  neurologic  outcomes.  Multivariate  analyses  indi-
cated  that  high  rSO2 was  independently  associated  with  good  neurologic  outcomes  (odds  ratio  =  14.07,
P  < 0.001).  Patients  with  high  rSO2 showed  favourable  neurologic  prognoses  if they  had undergone  thera-
peutic  hypothermia  or coronary  angiography  (CPC1/2,  69%  [54/78]).  However,  24%  (25/103)  of  those  with
high  rSO2 did  not  undergo  these  procedures  and exhibited  unfavourable  neurologic  prognoses  (CPC1/2,
4% [1/25]).
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ntroduction
The advent of systematic bundled post-cardiac arrest inter-
entions (PCAI) has increased the likelihood of patients surviving
ith good neurologic function after out-of-hospital cardiac arrests
OHCA).1,2 In particular, therapeutic hypothermia (TH) and per-
utaneous coronary intervention (PCI) with emergent coronary
ngiography (CAG) have been reported to improve the prognoses
f patients following OHCA of presumed cardiac cause.2–4
On the other hand, recent studies have shown that TH does not
rovide a beneﬁcial effect following OHCA.5,6 In fact, brain dam-
ge severity estimations and outcome prognoses for OHCA patients
ere found to be inaccurate,7,8 implying that stratiﬁcation before
r imbalance corrections after randomisation might have been
roblematic in many previous studies. Additionally, the absence of
ppropriate measurements for brain damage severity estimations
nd prognosis determinations might make it difﬁcult to perform
tratiﬁed randomisations in clinical trials involving patients expe-
iencing OHCA of presumed cardiac cause.9 Thus, better prognostic
actors are needed to elucidate ‘true indications’ of PCAI outcomes
ollowing such events.
Regional cerebral oxygen saturation (rSO2) is a measure of cere-
ral perfusion that is obtained noninvasively via near-infrared
pectroscopy and monitored in patients during cardiac arrest since
he instrument does not require vascular pulsation.10,11 We  previ-
usly reported that rSO2, measured upon arrival at the hospital,
ight help predict neurologic outcomes in patients following
HCA.12 However, few studies have focused on whether rSO2
easurements are effective for estimating brain damage severity,
or determining prognoses, or in the decision-making process for
CAI in patients who have experienced OHCA of presumed car-
iac cause.13 Therefore, this study aimed to evaluate the clinical
sefulness of rSO2 monitoring to estimate the severity of brain
amage and determine the prognoses of patients following OHCA
f presumed cardiac causes.
ethods
tudy design and setting
The Japan-Prediction of Neurological Outcomes in Patients Post-
ardiac Arrest (J-POP) Registry is a prospective multicentre cohort
tudy, and 15 Japanese tertiary emergency care hospitals partic-
pated in the J-POP during the study period (15 May  2011 to 30
ugust 2013). The inclusion criterion was unresponsiveness dur-
ng and after resuscitation upon arrival at the hospital following
n OHCA. The exclusion criteria included (1) trauma, (2) acci-
ental hypothermia, (3) age <18 years, (4) completion of the ‘Do
ot Attempt Resuscitation’ form, and (5) a Glasgow coma scale
GCS) score >8 upon arrival at the hospital. The details of theblished  by Elsevier  Ireland  Ltd. This is  an open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
J-POP registry design and main outcomes have been published
elsewhere.12
To identify the value of emergency room rSO2 measurements in
the PCAI (including TH and CAG) decision-making process, we  ana-
lysed 1195 consecutive patients with OHCA of presumed cardiac
cause from the J-POP registry.
Emergency medical care in Japan
In Japan, emergency lifesaving technicians are permitted to
insert tracheal tubes and administer intravenous adrenaline
(epinephrine).14 All emergency medical service providers perform
cardiopulmonary resuscitation (CPR) according to the current CPR
guidelines.15,16 However, the providers are not permitted to termi-
nate CPR in the ﬁeld.
Procedures after arrival at the hospital
All patients received advanced life support in accordance with
national guidelines. If sustained return of spontaneous circulation
(ROSC), i.e. the restoration of a palpable pulse that is sustained for
at least 20 min, was not obtained using standard advanced life sup-
port, patients with initially documented ventricular ﬁbrillation or
pulseless ventricular tachycardia received extracorporeal CPR and
extracorporeal circulatory support or a cardiopulmonary bypass. If
patients obtained sustained ROSC, TH was induced once their sys-
tolic blood pressure exceeded 90 mmHg  and their GCS score was
3–8.5,17,18 All procedural (e.g., extracorporeal CPR, CAG, PCI, and
TH) and diagnostic decisions were made at the discretion of the
attending physician(s).
Data collection
Data were prospectively collected according to the Utstein
style.19,20 Baseline patient characteristics and in-hospital data were
collected from medical records and databases.
Cardiac arrest was deﬁned as the absence of spontaneous res-
piration, a palpable pulse, and stimuli responsiveness.19 The arrest
was presumed to be of cardiac origin unless it was  due to cere-
brovascular disease, respiratory disease, external factors (e.g., drug
overdose or asphyxia), or other non-cardiac factors.
Near-infrared spectroscopy
Upon arrival at the hospital, 2 disposable near-infrared spec-
trometer (INVOSTM 5100C; Covidien, Boulder, CO, USA) probes
were carefully applied to both sides of the patient’s forehead.
After several seconds of stabilisation, rSO was monitored using2
the probes for at least 1 min, and the lowest rSO2 reading was
recorded.11,12,21
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The primary endpoint was the patients’ 90-day neurologic
utcomes, categorised according to the Glasgow–Pittsburgh cere-
ral performance categories (CPC), described in the Utstein style
uidelines.19 The guidelines categorise CPC 1 (good performance)
nd CPC 2 (moderate disability) as ‘good neurologic outcomes’,
hereas CPC 3 (severe disability), CPC 4 (vegetative state), and CPC
 (brain death or death) are deﬁned as ‘poor neurologic outcomes’.
ndividual patient CPC were determined by at least 2 physicians-
n-charge who were blinded to the rSO2 readings determined upon
rrival at the hospital.
tatistical analyses
Unpaired t-tests or Mann–Whitney U-tests were conducted for
npaired comparisons. A 2 or Fischer’s exact test was  conducted to
xamine differences between categorical variables. Receiver oper-
ting characteristic curve (ROC) analysis was performed to evaluate
he accuracy of predicted post-event good neurologic outcomes at
0 days. To analyse the effects of rSO2 on neurologic outcomes, we
eveloped logistic regression models that were adjusted for a pulse
etectable upon arrival at the hospital, deﬁbrillation before arrival
t the hospital, bystander-initiated CPR, age, male sex, use of an
dvanced airway device before arrival at the hospital, and intra-
enous epinephrine administration before arrival at the hospital,
n addition to rSO2 upon arrival at the hospital. The JMP  (ver-
ion 10.0.0, SAS Institute, Cary, NC, USA) and STATA (version 11.1,
tata, College Station, TX, USA) software were used for all statisticalanalyses. All reported probability values are 2-tailed, and P < 0.05
was considered statically signiﬁcant.
Ethical considerations
This study complied with the Declaration of Helsinki and con-
formed to the Guidelines for Epidemiologic Studies issued by the
Ministry of Health, Labour, and Welfare of Japan. The study protocol
was approved by the institutional review board or ethics commit-
tee of each participating medical institution, which also waived the
requirement for informed consent.
Results
General patient characteristics and outcomes
During the study period, the registry accumulated data on 3086
consecutive OHCA patients who were referred to the 15 partic-
ipating hospitals. In accordance with the study protocol, 1921
consecutive patients were enrolled, and 1195 patients with OHCA
of presumed cardiac cause were included in the analysis (Fig. 1).
Table 1 shows the characteristics and neurologic outcomes of
all patients. Among all patients, 880 (74%) were pronounced dead
in the emergency department. Of the remaining 315 patients, 223
(19%) died after admission to the hospital, whereas 92 (8%) sur-
vived for at least 90 days. After 90 days, 55 (5%), 13 (1%), 6 (0.5%),
and 18 (2%) patients were classiﬁed as CPC 1, 2, 3, and 4, respec-
tively. Accordingly, 68 patients (6%) were considered to have good
neurologic outcomes (CPC 1 or 2).
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<40% upon arrival at
the hospital (n = 1092)
Patients with rSO2
≥40% upon arrival at
the hospital (n = 103)
P-value*
rSO2 at arrival at the hospital, mean (SD) 21 (13) 18 (5) 58 (12) <0.001
Age,  years, mean (SD) 72 (15) 73 (15) 65 (17) <0.001
Male  sex, n (%) 756 (63) 674 (62) 82 (80) <0.001
Location of cardiac arrest, n (%)
Home 813 (68) 771 (71) 42 (41) <0.001
Nursing home/Assisted living 104 (9) 93 (9) 11 (11)
Public  building 55 (5) 42 (4) 13 (13)
Street  94 (8) 76 (7) 18 (17)
Other  129 (11) 110 (10) 19 (18)
Type  of bystander-witness status, n (%)
No witness 641 (54) 621 (57) 20 (19) <0.001
Family members 297 (25) 255 (23) 42 (41)
EMS  63 (5) 53 (5) 10 (10)
Other  194 (16) 163 (15) 31 (30)
Bystander-initiated CPR, n (%) 292 (24) 236 (22) 56 (54) <0.001
Initially documented rhythms on the scene of cardiac arrest, n (%) <0.001
VF/pulseless VT 189 (16) 137 (13) 52 (50)
PEA  257 (22) 237 (22) 20 (19)
Asystole/unknown 749 (63) 718 (66) 31 (30)
Pre-hospital procedures, n (%)
Advanced airway devices 703 (59) 655 (60) 48 (47) 0.008
Intravenous adrenaline administration 341 (29) 314 (29) 27 (26) 0.59
Deﬁbrillation 225 (19) 161 (15) 64 (62) <0.001
Emergency call to arrival at the hospital, min, mean (SD) 35 (13) 35 (12) 33 (19) <0.001
Rhythms at rSO2 measurement, n (%)
VF/pulseless VT 75 (6) 67 (6) 8 (8) <0.001
PEA  214 (18) 203 (19) 11 (11)
Asystole 817 (68) 806 (74) 11 (11)
Others  (pulse detectable upon arrival at the hospital) 89 (7) 16 (1) 73 (71)
Procedures after arrival at the hospital, n (%)
Extracorporeal CPR 95 (8) 84 (8) 11 (11) 0.28
Therapeutic hypothermia 154 (13) 86 (8) 68 (66) <0.001
Coronary angiography 135 (11) 78 (7) 57 (55) <0.001
Primary percutaneous coronary intervention 64 (5) 43 (4) 21 (20) <0.001









pPC, cerebral performance category; CPR, cardiopulmonary resuscitation; EMS, eme
aturation; SD, standard deviation; VF, ventricular ﬁbrillation; VT, ventricular tachy
* Comparing patients with rSO2 ≥40% and those with rSO2 <40% upon arrival at t
egional cerebral oxygen saturation upon arrival at the hospitalWe  observed a mean (±standard deviation) rSO2 of 21 ± 13%
pon arrival at the hospital (Table 1). According to the ROC curve
nalysis, the optimal cut-off for predicting good 90-day neurologic
ig. 2. Receiver operating characteristic curve analysis of regional cerebral oxygen satura
nd  neurologic outcomes according to regional cerebral oxygen saturation cut-off values. A
erformance category; ROC, receiver operating characteristic; ROSC, return of spontaneoy medical service; PEA, pulseless electrical activity; rSO2, regional cerebral oxygen
; OHCA, out-of-hospital cardiac arrest.
spital.
outcomes was an rSO2 ≥40% (sensitivity 0.81, 95% conﬁdence inter-
val [CI] 0.70–0.89; speciﬁcity 0.96, 95% CI 0.94–0.97; area under the
curve [AUC] 0.92, 95% CI 0.91–0.934; P < 0.001; Fig. 2).
The characteristics and neurologic outcomes of patients with
rSO2 ≥40% (n = 103) and <40% (n = 1092) upon arrival at the hospital
tion upon arrival at the hospital as a predictor of good 90-day neurologic outcomes
UC, area under the curve; CI, conﬁdence interval; CPC, Glasgow–Pittsburgh cerebral
us circulation; rSO2, regional cerebral oxygen saturation.
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Fig. 3. Neurologic outcomes at 90 days, based on regional cerebral oxygen saturation cut-off values upon arrival at the hospital, in patients with an undetectable pulse or
comatose patients with a detectable pulse upon arrival at the hospital, and in those undergoing or not undergoing therapeutic hypothermia and/or an emergent coronary
























aomatose patients with a detectable pulse upon arrival at the hospital; (b) neuro
pon  arrival) at the hospital in patients undergoing or not undergoing therapeutic h
lasgow–Pittsburgh cerebral performance category; OHCA, out-of-hospital cardiac
re shown in Table 1. Good neurologic outcomes were observed for
3% (55/103) and 1% (13/1092) of the patients with rSO2 ≥40% and
40%, respectively (P < 0.001, Fig. 2).
Of the 89 comatose patients whose pulse could be detected upon
rrival at the hospital, 73 had rSO2 ≥40% and 16 had rSO2 <40%
Fig. 3). Among these patients, 46 (63%) patients with high rSO2
easures had good neurologic outcomes. None of these patients
ad low rSO2 (P < 0.001). Of the 1106 patients whose pulse could
ot be detected upon arrival at the hospital, 30 had rSO2 ≥40% and
076 had rSO2 <40% (Fig. 3). Among these patients, good neuro-
ogic outcomes were observed for 9 (30%) patients with high rSO2
easures and 13 (1%) with low rSO2 (P < 0.001).
ultivariate analyses for good neurologic outcomes
Multivariate analyses (adjusted for prehospital patient char-
cteristics that showed a signiﬁcant univariate association with
utcomes) for good neurologic outcomes associated with prehos-
ital variables and high (≥40%) rSO2 indicated that high rSO2 was
ndependently associated with good neurologic outcomes (odds
atio 14.07, 95% CI 5.01–39.86, P < 0.001, AUC 0.96; Table 2).
able 2
ultivariate analysis for good neurologic outcomes, adjusted for prehospital variables an
rSO2 ≥40% upon arrival
at the hospital
Good neur
n/total n (%) n/total n (%
rSO2 ≥40% upon arrival at the hospital N/A 55/103 (53
Deﬁbrillation before arrival at the
hospital
64/225 (28) 53/225 (24
Pulse  detectable upon arrival at the
hospital
73/89 (82) 46/89 (52)
Bystander-initiated CPR 56/292 (19) 45/292 (15
Age  (1 year older) N/A 59/560 (11
Intravenous adrenaline administration
before arrival at the hospital
27/341 (8) 12/341 (7)
Male
sex
82/756 (11) 58/756 (8)
Advanced airway devices before arrival
at the hospital
48/703 (7) 24/703 (3)
I, conﬁdence interval; CPR, cardiopulmonary resuscitation; N/A, not applicable; OHCA, o
* Adjusted for the following variables: pulse detectable at arrival at the hospital, deﬁbr
dvanced airway devices before arrival at the hospital, and intravenous adrenaline adminutcomes at 90 days (based on regional cerebral oxygen saturation cut-off values
ermia and/or an emergent coronary angiography. CAG, coronary angiography, CPC,
; rSO2, regional cerebral oxygen saturation; TH, therapeutic hypothermia.
Post-cardiac arrest interventions
Extracorporeal CPR, TH, CAG, and PCI were performed in 95 (8%),
154 (13%), 135 (11%), and 64 (5%) patients, respectively.
A higher proportion of patients who  underwent TH had good
neurologic outcomes (CPC1/2; 36%) than those not undergoing TH
(CPC1/2; 1%, P < 0.001). Similarly, a higher proportion of patients
who underwent a CAG had good neurologic outcomes (CPC1/2;
41%) than those who  did not (CPC1/2; 1%, P < 0.001). Last, patients
who underwent TH or a CAG showed signiﬁcantly more favourable
characteristics (Table 1).
Furthermore, more than two thirds of patients with rSO2 ≥40%
who underwent TH or a CAG showed good neurologic outcomes
(CPC1/2; 69%; Fig. 3), and this rate of good neurologic outcomes
rate was  signiﬁcantly higher than in patients with rSO2 <40%
who underwent the same procedures (CPC1/2; 11%; P < 0.001).
However, among patients with rSO2 ≥40%, 24% (25/103) did not
undergo TH or a CAG. These patients exhibited a signiﬁcantly lower
rate of good neurologic outcomes than those undergoing TH or a
CAG (CPC1/2; 4% vs. 69%, respectively; P < 0.001; Fig. 3). Many of
these patients had other unfavourable characteristics such as older
age, OHCA at home, no witnesses, no bystander-initiated CPR, no
d regional cerebral oxygen saturation >40%.
ologic outcome 90 days after OHCA
) Odds ratio (not
adjusted)
P value Odds ratio (adjusted for
prehospital variables)*
P-value
(95% CI) (95% CI)
) 95.1 <0.001 14.07 <0.001
48.66–185.86 5.04–39.86
) 19.62 <0.001 4.18 <0.001
10.81–35.60 1.86–9.62
52.71 <0.001 5.05 0.002
29.15–95.32 1.78–14.72
) 6.97 <0.001 3.20 0.002
4.14–11.75 1.52–6.88
) 0.95 <0.001 0.97 0.01
0.94–0.96 0.95–0.99
0.52 0.032 0.52 0.17
0.26–0.95 0.19–1.31
3.56 <0.001 2.01 0.17
1.80–7.05 0.75–5.94
0.36 <0.001 0.68 0.35
0.22–0.60 0.61–1.52
ut-of-hospital cardiac arrest.
illation before arrival at the hospital, bystander-initiated CPR, age, male sex, use of
istration before arrival at the hospital.
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Table 3
Characteristics of patients with high regional cerebral oxygen saturation (>40%) upon arrival at the hospital undergoing or not undergoing therapeutic hypothermia and/or












rSO2 upon arrival at the hospital, mean (SD) 60 (12) 51 (8) <0.001
Age,  years, mean (SD) 61 (15) 76 (18) <0.001
Male  sex, n (%) 65 (83) 17 (68) 0.15
Location of cardiac arrest, n (%) <0.001
Home  26 (3) 16 (64)
Nursing home/assisted living 5 (6) 6 (24)
Public building 13 (17) 0 (0)
Street  17 (22) 1 (4)
Others 17 (22) 2 (8)
Type  of bystander-witness status, n (%) <0.001
No  witness 9 (12) 11 (44)
Family members 31 (40) 11 (44)
EMS  8 (10) 2 (8)
Others 30 (38) 1 (4)
Bystander-initiated CPR, n (%) 48 (61) 8 (32) 0.012
Initially documented rhythms on the scene of cardiac arrest, n (%) <0.001
VF/pulseless VT 48 (62) 4 (16)
PEA  10 (13) 10 (40)
Asystole/unknown 20 (26) 11 (44)
Pre-hospital procedures, n (%)
Advanced airway devices 33 (42) 15 (60) 0.17
Intravenous adrenaline administration 15 (19) 12 (48) 0.008
Deﬁbrillation 59 (76) 5 (20) <0.001
Emergency call to arrival at the hospital, min, mean (SD) 32 (20) 36 (13) 0.01
Rhythms at rSO2 measurement, n (%)
VF/pulseless VT 6 (8) 2 (8)
PEA  6 (8) 5 (20)
Asystole 4 (5) 7 (28)






























PCPC  1 or 2 at 90 days, n (%) 5
PR, cardiopulmonary resuscitation; EMS, emergency medical service; OHCA, out-o
aturation; SD, standard deviation; VF, ventricular ﬁbrillation; VT, ventricular tachy
hockable rhythms, and no detectable pulse upon arrival at the
ospital (Table 3).
iscussion
Our results show that high rSO2 upon arrival at the hospital
redicted good 90-day neurologic outcomes with high sensitivity,
peciﬁcity, and AUC (optimal cut-off, rSO2 ≥40%) in patients experi-
ncing OHCA of presumed cardiac cause. These data are consistent
ith our previous report on all non-trauma OHCA patients in the
-POP Registry.12 Half of the patients (55/108, 51%) with rSO2 ≥40%
pon arrival at the hospital had good neurologic outcomes. Surpris-
ngly, even if a pulse was not detectable upon arrival at the hospital,
0% of patients (9/30) with high rSO2 demonstrated good neuro-
ogic outcomes. In contrast, none of the patients (0/19) with low
SO2 had good neurologic outcomes, even if a pulse was  detected
pon arrival at the hospital. These compelling results show that
SO2 monitoring is a promising method for selecting good can-
idates for PCAI (including TH, CAG, and PCI). To the best of our
nowledge, this is the ﬁrst report demonstrating the clinical use-
ulness of rSO2 measurements for estimating brain damage severity
nd predicting outcomes in patients with OHCA of presumed car-
iac origin.
As reported by Ito et al. 2/446 (0.4%) patients demonstrated
ood 90-day neurologic outcomes despite having low rSO2 (15%)
pon arrival at the hospital, implying that rSO2 values alone can-
ot be used to determine whether resuscitative efforts should be
erminated. Therefore, rSO2 monitoring is useful for determining
hich patients will likely have good neurologic outcomes follow-
ng OHCA of presumed cardiac cause (i.e. which patients are good
CAI candidates).12 1 (4) <0.001
ital cardiac arrest; PEA, pulseless electrical activity; rSO2, regional cerebral oxygen
.
Many studies have shown strong positive effects of bundled
PCAI for improving post-cardiac arrest outcomes.1,2,22 Another
multicentre registry study in Japan reported that 55% of OHCA
patients had good neurologic prognoses after PCAI.23 In the present
study, up to 69% of patients with rSO2 ≥40% showed good neuro-
logic prognoses if they underwent PCAI. Thus, monitoring rSO2 in
the emergency room, following OHCA of presumed cardiac cause,
provides a good indication of the 90-day neurologic outcomes fol-
lowing PCAI. However, in the present study, approximately 25%
patients with high rSO2 did not undergo TH or a CAG and these
patients exhibited a signiﬁcantly lower rate of good neurologic
outcomes than those undergoing TH or a CAG (CPC1/2; 4% vs.
69%, respectively; P < 0.001; Fig. 3). High rSO2 values upon hospi-
tal arrival indicated that the patients did not suffer from severe
hypoxic cerebral damage. Thus, we  hypothesised that rSO2 was  an
intermediate factor in the process of cerebral damage formation
after OHCA, and that high rSO2 values upon hospital arrival indi-
cated that the patients might be good candidates for PCAI even
if they had unfavourable characteristics. In fact, as unfavourable
characteristics were relatively common among these patients, PCAI
might have been underutilised in these individuals. Further studies
are needed to determine whether patients in this group are good
candidates for PCAI.
TH at a target temperature of 33 ◦C was  recently reported to not
confer a beneﬁt over TH at a target temperature of 36 ◦C,6 implying
the overuse of PCAI. Rittenberger et al.24 remarked that future stud-
ies should continue to deﬁne patient subgroups that would beneﬁt
from speciﬁc therapies and clarify protocols for such interventions,
based on each patient’s illness, including a mandatory estimation
of brain damage severity. Further studies are needed to clarify




























































2K. Nishiyama et al. / Res
redicting brain damage severity and making decisions regarding
CAI administration.
This study has several limitations. Although we previously
eported that continuous rSO2 monitoring would be desirable prior
o arrival at the hospital, the absence of portable near-infrared spec-
roscopy devices makes this impossible.12 Second, near-infrared
pectroscopy rSO2 measurements reﬂect only cerebral perfusion
n the superﬁcial layers of limited frontal lobe areas, and rSO2 is
ot a reliable marker of brain tissue oxygen partial pressure.10–12
hird, we could not blind the investigators to the rSO2 values
ecause rSO2 monitoring requires real-time visual conﬁrmation.
s per a pre-speciﬁed protocol, all patients received the best avail-
ble therapy, regardless of their rSO212; however, we could not
liminate the possibility that low rSO2 might have inﬂuenced the
ecision to terminate resuscitation. Fourth, as emergency med-
cal service providers in Japan are not permitted to terminate
PR, most OHCA patients who are treated by these personnel are
ransported to emergency departments. Thus, a very small propor-
ion of patients with documented rhythms at the scene of cardiac
rrest demonstrated ventricular tachycardia/ﬁbrillation and had
ery poor 90-day neurologic outcomes. Hence, the international
alidity of this study might be limited. Finally, this study was  not
andomised, and to assess the predictive value of a clinical tool,
recise validation cohorts are needed to verify our observations.
onclusions
In conclusion, our study shows that rSO2 ≥40% upon arrival
t the hospital predicted good 90-day neurologic outcomes in
atients suffering OHCA of presumed cardiac cause, even if a pulse
as undetectable upon arrival at the hospital. Patients with rSO2
40% upon arrival at the hospital who underwent PCAI showed
emarkably favourable neurologic prognoses. Thus, rSO2 monitor-
ng following OHCA of presumed cardiac cause is an indicator of
0-day neurologic outcomes following PCAI. However, about 25%
f patients with rSO2 ≥40% in our study did not undergo TH or a CAG
nd had quite poor neurologic outcomes, implying that PCAI might
e underutilised in these cases. Future studies are necessary to
valuate the efﬁciency of rSO2 monitoring during the PCAI decision-
aking process following OHCA of presumed cardiac cause.
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